{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:03:58Z","timestamp":1793451838321,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.reprotox.2025.109035","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T02:36:13Z","timestamp":1756434973000},"page":"109035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["New approach methodologies for assessing developmental toxicity of pharmaceuticals: Case examples and future directions"],"prefix":"10.1016","volume":"137","author":[{"given":"Nicola","family":"Powles-Glover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen R.","family":"Kaczor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Van Cruchten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly C.","family":"Brannen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Demarta-Gatsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"LeConte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Jamalpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumito","family":"Mikashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shermaine","family":"Mitchell-Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Stanislaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Theunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Tornesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Wange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3704-9866","authenticated-orcid":false,"given":"Connie L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.reprotox.2025.109035_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/toxsci\/kfab013","article-title":"FutureTox IV workshop summary: predictive toxicology for healthy children","volume":"180","author":"Knudsen","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2025.109035_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104592","article-title":"An evaluation framework for new approach methodologies (NAMs) for human health safety assessment","volume":"112","author":"Parish","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1-3","key":"10.1016\/j.reprotox.2025.109035_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.toxlet.2003.12.029","article-title":"Validation of alternative methods for developmental toxicity testing","volume":"149","author":"Piersma","year":"2004","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.reprotox.2025.109035_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/bdrc.20175","article-title":"In vitro developmental toxicology assays: a review of the state of the science of rodent and zebrafish whole embryo culture and embryonic stem cell assays","volume":"90","author":"Augustine-Rauch","year":"2010","journal-title":"Birth Defects Res C. Embryo Today"},{"issue":"3","key":"10.1016\/j.reprotox.2025.109035_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/026119290403200307","article-title":"Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests","volume":"32","author":"Piersma","year":"2004","journal-title":"Alter. Lab Anim."},{"key":"10.1016\/j.reprotox.2025.109035_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.reprotox.2019.02.004","article-title":"A multi-institutional study benchmarking the zebrafish developmental assay for prediction of embryotoxic plasma concentrations from rat embryo-fetal development studies","volume":"86","author":"Cassar","year":"2019","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2025.109035_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-62703-131-8_29","article-title":"Frog embryo teratogenesis assay on xenopus and predictivity compared with in vivo mammalian studies","volume":"947","author":"Leconte","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.reprotox.2025.109035_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/acs.chemrestox.5b00458","article-title":"In vitro developmental toxicology screens: a report on the progress of the methodology and future applications","volume":"29","author":"Zhang","year":"2016","journal-title":"Chem. Res. Toxicol."},{"issue":"10","key":"10.1016\/j.reprotox.2025.109035_bib9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/bdr2.1212","article-title":"Rethinking developmental toxicity testing: evolution or revolution?","volume":"110","author":"Scialli","year":"2018","journal-title":"Birth Defects Res."},{"issue":"12","key":"10.1016\/j.reprotox.2025.109035_bib10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/bdr2.2190","article-title":"Integration and application of new approach methodologies in assessing the developmental hazards: case study with an antimalarial drug","volume":"115","author":"Demarta-Gatsi","year":"2023","journal-title":"Birth Defects Res."},{"issue":"19","key":"10.1016\/j.reprotox.2025.109035_bib11","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/bdr2.2001","article-title":"A novel human stem cell-based biomarker assay for in vitro assessment of developmental toxicity","volume":"114","author":"Jamalpoor","year":"2022","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.reprotox.2025.109035_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153684","article-title":"Animal-free assessment of developmental toxicity: combining PBPK modeling with the ReproTracker assay","volume":"500","author":"Moreau","year":"2023","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.reprotox.2025.109035_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/bdrb.21078","article-title":"Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening","volume":"98","author":"Palmer","year":"2013","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109035_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.taap.2011.08.025","article-title":"Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics","volume":"257","author":"Kleinstreuer","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.reprotox.2025.109035_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/026119290203000204","article-title":"The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European centre for the validation of alternative methods","volume":"30","author":"Genschow","year":"2002","journal-title":"Alter. Lab Anim."},{"issue":"2","key":"10.1016\/j.reprotox.2025.109035_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/bdrb.20148","article-title":"Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry","volume":"83","author":"Paquette","year":"2008","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2025.109035_bib17","unstructured":"National Toxicology Program, Evaluation of FETAX for Developmental Toxicity, 1998."},{"key":"10.1016\/j.reprotox.2025.109035_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.721130","article-title":"Validation, optimization, and application of the zebrafish developmental toxicity assay for pharmaceuticals under the ICH S5(R3) guideline","volume":"9","author":"Song","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109035_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/toxsci\/kfv076","article-title":"Optimization and performance assessment of the Chorion-Off [Dechorinated] zebrafish developmental toxicity assay","volume":"146","author":"Panzica-Kelly","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2025.109035_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2023.108513","article-title":"Validation of a zebrafish developmental defects assay as a qualified alternative test for its regulatory use following the ICH S5(R3) guideline","volume":"123","author":"Weiner","year":"2024","journal-title":"Reprod. Toxicol."},{"issue":"8","key":"10.1016\/j.reprotox.2025.109035_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2131\/jts.49.337","article-title":"Validation of a new protocol for a zebrafish MEFL (malformation or embryo-fetal lethality) test method that conforms to the ICH S5 (R3) guideline","volume":"49","author":"Mori","year":"2024","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2025.109035_bib22","unstructured":"EMA, Regulatory Acceptance of 3R (Replacement, Reduction, Refinement) Testing Approaches, Scientific Guideline. EMA\/CHMP\/CVMP\/JEG-3Rs\/450091\/2012 (2017)."},{"key":"10.1016\/j.reprotox.2025.109035_bib23","unstructured":"US FDA, Oncology Pharmaceuticals: Reproductive Toxicity Testing and Labeling Recommendations Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2019."},{"key":"10.1016\/j.reprotox.2025.109035_bib24","unstructured":"ICH, Detection of Reproductive and Developmental Toxicity for Human Pharmaceuticals S5(R3), International Counsel For Harmonization of Technical Requirements for Pharmaceuticals for Human Use, 2020."},{"key":"10.1016\/j.reprotox.2025.109035_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yrtph.2019.04.005","article-title":"Analysis of exposure margins in developmental toxicity studies for detection of human teratogens","volume":"105","author":"Andrews","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.reprotox.2025.109035_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/bdrb.20276","article-title":"A different approach to validating screening assays for developmental toxicity","volume":"89","author":"Daston","year":"2010","journal-title":"Birth Defects Res B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2025.109035_bib27","unstructured":"ICH, Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility S5(R2), International Counsel For Harmonization of Technical Requirements for Pharmaceuticals for Human Use, 1994."},{"key":"10.1016\/j.reprotox.2025.109035_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108686","article-title":"New approach methodologies to confirm developmental toxicity of pharmaceuticals based on weight of evidence","volume":"129","author":"Catlin","year":"2024","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109035_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12936-022-04137-2","article-title":"Re-orienting anti-malarial drug development to better serve pregnant women","volume":"21","author":"El Gaaloul","year":"2022","journal-title":"Malar. J."},{"key":"10.1016\/j.reprotox.2025.109035_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104984","volume":"124","author":"McNerney","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.reprotox.2025.109035_bib31","unstructured":"US FDA, Drug Development Tool (DDT) Qualification Programs. Available at: \u3008https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/drug-development-tool-ddt-qualification-programs\u3009."},{"key":"10.1016\/j.reprotox.2025.109035_bib32","unstructured":"US FDA, Guidance Document: Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff. Available at: \u3008https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/qualification-process-drug-development-tools-guidance-industry-and-fda-staff\u3009, 2020."},{"key":"10.1016\/j.reprotox.2025.109035_bib33","unstructured":"US FDA, Biomarker Qualification Program. Available at: \u3008https:\/\/www.fda.gov\/drugs\/drug-development-tool-ddt-qualification-programs\/biomarker-qualification-program\u3009."},{"key":"10.1016\/j.reprotox.2025.109035_bib34","unstructured":"US FDA, Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. Available at: \u3008https:\/\/www.fda.gov\/drugs\/drug-development-tool-ddt-qualification-programs\/innovative-science-and-technology-approaches-new-drugs-istand-pilot-program\u3009."},{"key":"10.1016\/j.reprotox.2025.109035_bib35","unstructured":"US FDA, Roadmap to Reducing Animal Testing in Pharmaceutical Safety Studies, 2025. \u3008https:\/\/www.fda.gov\/media\/186092\/download?attachment\u3009. (Accessed June 19, 2025 2025)."},{"key":"10.1016\/j.reprotox.2025.109035_bib36","unstructured":"EMA, Supporting innovation. Available at: \u3008https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/innovation-medicines#ema's-innovation-task-force\u3009-(itf)-section."},{"key":"10.1016\/j.reprotox.2025.109035_bib37","unstructured":"EMA, Scientific advice and protocol assistance. Available at: \u3008https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/scientific-advice-protocol-assistance\u3009."},{"key":"10.1016\/j.reprotox.2025.109035_bib38","unstructured":"EMA, Qualification of novel methodologies for medicine development. Available at: \u3008https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/scientific-advice-protocol-assistance\/qualification-novel-methodologies-medicine-development-0\u3009."},{"key":"10.1016\/j.reprotox.2025.109035_bib39","unstructured":"EMA, Guideline on the principles of regulatory acceptance of 3Rs (replacement, reduction, refinement) testing approaches. EMA\/CHMP\/CVMP\/JEG-3Rs\/450091\/2012. Available at \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-principles-regulatory-acceptance-3rs-replacement-reduction-refinement-testing-approaches_en.pdf\u3009, 2016."},{"key":"10.1016\/j.reprotox.2025.109035_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-025-00052-8","article-title":"Insights into new approach methodology innovation: an EMA perspective","author":"Edwards","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.reprotox.2025.109035_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-025-00053-7","article-title":"New approach methodologies: EU regulatory horizons","author":"Edwards","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"18","key":"10.1016\/j.reprotox.2025.109035_bib42","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/bdr2.1798","article-title":"Teratogen update: malaria in pregnancy and the use of antimalarial drugs in the first trimester","volume":"112","author":"Clark","year":"2020","journal-title":"Birth Defects Res."},{"issue":"10371","key":"10.1016\/j.reprotox.2025.109035_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(22)01881-5","article-title":"Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis","volume":"401","author":"Saito","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.reprotox.2025.109035_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/toxsci\/kft235","article-title":"Multidimensional in vivo hazard assessment using zebrafish","volume":"137","author":"Truong","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109035_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/aivt.2017.0008","article-title":"Use of alternative developmental toxicity assays to assess teratogenicity potential of pharmaceuticals","volume":"4","author":"Green","year":"2018","journal-title":"Appl. Vitr. Toxicol."},{"issue":"8","key":"10.1016\/j.reprotox.2025.109035_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/bdr2.2389","article-title":"Absence of developmental and reproductive toxicity in rats, rabbits, and zebrafish embryos exposed to antimalarial drug cabamiquine","volume":"116","author":"Gado","year":"2024","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.reprotox.2025.109035_bib47","unstructured":"US FDA, Study Data Technical Conformance Guide: Technical Specifications Document. Available at: \u3008https:\/\/www.fda.gov\/media\/153632\/download\u3009, 2025."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825002060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825002060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:08:17Z","timestamp":1757768897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623825002060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":47,"alternative-id":["S0890623825002060"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.109035","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New approach methodologies for assessing developmental toxicity of pharmaceuticals: Case examples and future directions","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.109035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109035"}}